Structure | Chemical Name | CAS | MF |
|
2-CBZ-AMINO-HEPTA-3,6-DIENOIC ACID METHYL ESTER
|
|
C16H19NO4
|
|
2-CBZ-AMINOTHIAZOLE-4-CARBOXYLIC ACID
|
|
C12H10N2O4S
|
|
CBZ-A-METHYL-L-GLU
|
|
C14H17NO6
|
|
2-CBZ-AMINO-5-(5-METHYLFURAN-2-YL)PENT-3-ENOIC ACID METHYL ESTER
|
|
C19H21NO5
|
|
2-CBZ-AMINO-INDAN-2-CARBOXYLIC ACID
|
91733-75-4
|
C18H17NO4
|
|
2-CBZ-AMINO-BUT-2-ENOIC ACID METHYL ESTER
|
70396-37-1
|
C13H15NO4
|
|
3-(CBZ-AMINO)AZETIDINE
|
|
C11H14N2O2
|
|
[4-(2-CBZ-AMINO-ETHYL)-PHENYL]-ACETIC ACID
|
885278-15-9
|
C18H19NO4
|
|
CBZ-1-AMINO-1-CYCLOHEPTANECARBOXYLIC ACID
|
197794-44-8
|
C16H21NO4
|
|
2-CBZ-AMINO-4-ETHYLHEX-2-ENOIC ACID METHYL ESTER
|
|
C17H23NO4
|
|
2-CBZ-AMINO-5-(4-METHOXYPHENYL)PENT-2-ENOIC ACID METHYL ESTER
|
|
C21H23NO5
|
|
2-CBZ-AMINO-5-(5-METHYLFURAN-2-YL)PENT-2-ENOIC ACID METHYL ESTER
|
|
C19H21NO5
|
|
5-(CBZ-AMINO)-1-(4-FLUORO-PHENYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID
|
1017781-26-8
|
C18H14FN3O4
|
|
3-CBZ-AMINO-BUTYLAMINE
|
885277-95-2
|
C12H18N2O2
|
|
2-CBZ-AMINO-HEXA-2,4-DIENOIC ACID METHYL ESTER
|
|
C15H17NO4
|
|
2-CBZ-AMINO-5-PHENYLPENT-3-ENOIC ACID METHYL ESTER
|
|
C20H21NO4
|
|
(4-CBZ-AMINOPHENYL)BORONIC ACID
|
192804-36-7
|
C14H14BNO4
|
|
2-(CBZ-AMINO)-2-(4'-HYDROXYPHENYL)ACETIC ACID
|
36747-66-7
|
C16H15NO5
|
|
CBZ-2-AMINO-2-FURANACETIC ACID
|
61886-78-0
|
C14H13NO5
|
|
CBZ-1-AMINO-2,2-DIMETHYLCYCLOPROPANECARBOXYLIC ACID
|
|
C14H17NO4
|
|
1-CBZ-AMINO-2,2-DIMETHYL-1,3-PROPANEDIAMINE
|
|
C13H20N2O2
|
|
CBZ-8-AMINO-3,6-DIOXAOCTANOIC ACID DCHA
|
165454-06-8
|
C14H19NO6
|
|
1-CBZ-AMINO-2-BOC-AMINO-ETHANE
|
77153-05-0
|
C15H22N2O4
|
|
Cbz-beta-Amino-L-alanine
|
35761-26-3
|
C11H14N2O4
|
|
CBZ-BETA-N-METHYLAMINO-D-ALA
|
|
C12H16N2O4
|
|
CBZ-BETA-N-BENZYLAMINO-D-ALA
|
|
C18H20N2O4
|
|
CBZ-BETA-AMINO-D-ALANINE
|
62234-37-1
|
C11H14N2O4
|
|
CBZ-BETA-N,N-DIETHYLAMINO-L-ALA
|
|
C15H22N2O4
|
|
CBZ-BETA-N,N-DIMETHYLAMINO-L-ALA
|
|
C13H18N2O4
|
|
CBZ-BETA-N-ETHANOLAMINO-D-ALA
|
|
C13H18N2O5
|
|
C2-C6 OLEFINS
|
|
|
|
CBZ-BETA-N-METHYLAMINO-L-ALA
|
|
C12H16N2O4
|
|
CBZ-BETA-N-ETHANOLAMINO-L-ALA
|
|
C13H18N2O5
|
|
CBZ-BETA-N,N-DIMETHYLAMINO-D-ALA
|
|
C13H18N2O4
|
|
CBZ-BETA-N,N-DIETHANOLAMINO-D-ALA
|
|
C15H22N2O6
|
|
1-CBZ-2-BENZYL-PIPERIDIN-4-ONE
|
849928-35-4
|
C20H21NO3
|
|
CBZ-BETA-IMIDAZOLYL-D-ALA
|
|
C14H15N3O4
|
|
CBZ-BETA-IMIDAZOLYL-L-ALA
|
|
C14H15N3O4
|
|
CBZ-BETA-N,N-DIETHYLAMINO-D-ALA
|
|
C15H22N2O4
|
|
CBZ-BETA-AMINO-L-ALANINE TERT-BUTYL ESTER HYDROCHLORIDE
|
174796-88-4
|
C15H23ClN2O4
|
|
CBZ-BETA-N-BENZYLAMINO-L-ALA
|
|
C18H20N2O4
|
|
CBZ-BETA-N,N-DIETHANOLAMINO-L-ALA
|
|
C15H22N2O6
|
|
C1-C4 PARAFFINS
|
|
|
|
CBZ-arginyl-lysyl
|
|
C20H31N6O4*
|
|
C21-C28PARAFFINS
|
|
|
|
C10-C14PARAFFINIC/NAPHTHENICPETROLEUMSOLVENTAROMATICH.
|
|
|
|
CD95,FAS,48KD,CLONE:LOB3-17,MABANTI-HUMAN:FROZEN/NOPARAFFIN,IH/FLOW/NOWB
|
|
|
|
Cbz-Asn-ONp
|
|
|
|
Cbz-Asp-OBut
|
|
|
|
CD4 ELISA
|
|
|
|
CBZ-ASP-TYR(SO3H)-MET-GLY-TRP-MET-ASP-NH2
|
|
C48H59N9O17S3
|
|
CBZ-4-BIPHENYL-L-ALA
|
270568-72-4
|
C23H21NO4
|
|
CBZ-ASP(OBZL)-OBZL
|
5241-60-1
|
C26H25NO6
|
|
Cbz-Asp(OCHEX)-OH
|
|
|
|
CBZ-4-BIPHENYL-D-ALA
|
176794-80-2
|
C23H21NO4
|
|
CD95,FAS,APO-1,CLONE:FAS18,MABANTI-HUMAN,INDUCESAPOPTOSIS
|
|
|
|
CD95,FAS,APO-1,CLONE:FAS19,MABANTI-HUMAN,FITC,INHIBITSINDUCTIONOFAPOPTOSISBYFAS18
|
|
|
|
CD95,FAS,48KD,CLONE:GM30,MABANTI-HUMAN:FROZEN/PARAFFIN,IH/NOWB
|
|
|
|
CD95,FASANTIGEN,40-45KD,CLONE:G-30,MABANTI-HUMAN:FROZEN/PARAFFIN,IH/FLOW
|
|
|
|
CD95,FAS,APO-1,CLONE:FAS19,MABANTI-HUMAN,INHIBITSINDUCTIONOFAPOPTOSISBYFAS18
|
|
|
|
1-Cbz-3-carbamoylpiperidine
|
|
C14H18N2O3
|
|
1-CBZ-4-(3-CARBOXY-PROPYL)-PIPERIDINE
|
|
C17H23NO4
|
|
1-CBZ-4-(4-CARBOXY-PHENYL)-PIPERIDINE
|
885274-62-4
|
C20H21NO4
|
|
CD49D,VLA-A4,INTEGRINA4,GP150,CLONE:15A8,MABANTI-HUMAN
|
|
|
|
CD49D,VLA-A4,INTEGRINA4,CLONE:R1-2,RATMABANTI-MOUSE,BIOTIN
|
|
|
|
Cd49DVlaAlpha-4Chain(LymphocyteHomingReceptor)
|
|
|
|
CD49D,VLA-A4,INTEGRINA4,CLONE:R1-2,RATMABANTI-MOUSE
|
|
|
|
CCNU-VP protocol
|
|
|
|
CD49D,VLA-A4,INTEGRINA4,CLONE:R1-2,RATMABANTI-MOUSE,FITC
|
|
|
|
CD49D,VLA-A4,INTEGRINA4,CLONE:R1-2,RATMABANTI-MOUSE,PE
|
|
|
|
CD115/FC CHIMERA HUMAN
|
|
|
|
C-DeMethyl ClethodiM
|
112301-96-9
|
C16H24ClNO3S
|
|
C-DeMethyl ForMoterol FuMarate
(Mixture of DiastereoMers)
|
|
C22H26N2O8
|
|
4-Cbz-1-Boc 2-(hydroxyMethyl)piperazine
|
557056-07-2
|
C18H26N2O5
|
|
1-CBZ-4-(BOC-AMINO)PIPERIDINE
|
159874-20-1
|
C18H26N2O4
|
|
CD23,FCERII,B-CELL,45KD,CLONE:MHM6,MABANTI-HUMAN,FITC:FLOW
|
|
|
|
CD23,FCERII,B-CELL,45KD,CLONE:MHM6,MABANTI-HUMAN
|
|
|
|
CD23,FCERII,B-CELL,45KD,CLONE:MHM6,MABANTI-HUMAN:FROZEN/NOPARAFFIN
|
|
|
|
CD23,FCERII,B-CELL,GP45-50,CLONE:T,MABANTI-HUMAN,FITC
|
|
|
|
CD23,FCERII,B-CELL,45KD,CLONE:1B12,MABANTI-HUMAN
|
|
|
|
CD23,FCERII,B-CELL,45KD,CLONE:MHM6,MABANTI-HUMAN,RPE
|
|
|
|
1-CBZ-3-BOC-AMINO PYRROLIDINE
|
185057-49-2
|
C17H24N2O4
|
|
2-Azaspiro[3.3]heptane-2,6-dicarboxylic acid, 2-(phenylmethyl) ester
|
1291487-33-6
|
C15H17NO4
|
|
CD40-FC FUSION PROTEIN, HUMAN
|
|
|
|
CD152-Fc Fusion Protein, Human, Recombinant, BHK Cell line
|
|
|
|
CD64,FCGRI,CLONE:10.1,MABANTI-HUMAN,RPE
|
|
|
|
CD64,FCGRI,CLONE:10.1,MABANTI-HUMAN
|
|
|
|
Cd32FcGammaR2Gp40Kda
|
|
|
|
CD64,FCGRI,CLONE:10.1,MABANTI-HUMAN,RPE-CY5
|
|
|
|
CD32,FCGRII,MACRO.,GRAN.,B-CELL,GP40,CLONE:CIKM5,MABANTI-HUMAN
|
|
|
|
CD32,FCGRII,CLONE:2E1,MABANTI-HUMAN:IH/FACS/IP/ELISA
|
|
|
|
CD64,FCGRI(HIGHAFFINITY),MONOCYTE,GP75,CLONE:10.1,MABANTI-HUMAN
|
|
|
|
1-CBZ-3-[(4-CHLOROPHENYL)METHYL]-3-PIPERIDINECARBOXYLIC ACID
|
197887-27-7
|
C21H22ClNO4
|
|
1-Cbz-3-(broMoMethyl)piperidine
|
242459-81-0
|
C14H18BrNO2
|
|
CD152:FC (HUMAN)-MULG FUSION PROTEIN FITC
|
|
|
|
CBZ CHOLECYSTOKININ-PZ 27-32, SULFATED
|
|
C44H57N9O14S3
|
|
Cbz-4-Chloro-D-Phenylalanine
|
|
C17H16ClNO4
|
|
Cbz-3-Chloro-L-Phenylalanin
|
|
C17H16ClNO4
|
|
Cbz-3-Bromo-D-Phenylalanine
|
|
C17H16BrNO4
|
|
Cbz-3-Chloro-D-Phenylalanine
|
1169765-66-5
|
C17H16ClNO4
|